Quantcast

Latest Clinical research Stories

2014-08-07 16:28:03

The Approved Gleostine(TM) Brand Name has Replaced the Discontinued Former Drug Name CeeNu® MIAMI, Aug. 7, 2014 /PRNewswire/ -- NextSource Biotechnology (NSB) is a leading specialty pharmaceutical manufacturer with a focus on identifying and developing the most viable pipeline of "matured" and "innovative drugs" in today's global healthcare market. http://photos.prnewswire.com/prnvar/20140124/FL52230LOGO The product name change from Lomustine (CCNU) to Gleostine(TM) represents the...

2014-08-06 23:02:13

Published since 2006, the Orange Paper gives detailed snapshot of clinical trials in Russia. Moscow, Russia (PRWEB) August 06, 2014 Synergy Research Group has released its Q2, 2014 Orange Paper. Published since 2006, the Synergy Orange Paper gives an unbiased and detailed view of the state of clinical trials in Russia. The report, which is issued quarterly, gives a strategic overview and drills down into additional data, such as the number of trials, top companies that initiated studies...

2014-08-06 12:29:33

SARASOTA, Fla., Aug. 6, 2014 /PRNewswire/ -- Rock Creek Pharmaceuticals, Inc., (NASDAQ: RCPI) announced that the Company has made two key independent appointments to the Company's Board of Directors with the recent election of Ms. Lee M. Canaan, CFA and Mr. Edward J. McDonnell, MPH. as new directors. http://photos.prnewswire.com/prnvar/20140806/134113 Both Ms. Canaan and Mr. McDonnell have substantial expertise, experience and knowledge relevant to the Company's mission and...

2014-08-05 23:12:10

On July 25, CaCoCo Inc. informed consumers that CaCoCo “Original” and “Global Warrior” are recalled due to possible health risks. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) August 05, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on raw drinking chocolate. CaCoCo Inc. informed consumers on...

2014-08-05 23:03:14

OMICS Group International schedules its 5th World Congress on Bioavailability and Bioequivalence: Pharmaceutical R&D Summit during September 29 to October 01, 2014 at Baltimore, USA with an aim to Revolutionize the Next Generation Medicines using innovative Bioavailability and Bioequivalence (BA/BE) approaches and Studies. Los Angeles, CA (PRWEB) August 05, 2014 Speaking for this occasion, CEO of the OMICS Group International, Dr. Srinubabu Gedela observed that several high profile...

2014-08-05 12:31:12

TUCSON, Ariz., Aug. 5, 2014 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announces a new agreement with Quintiles, Inc. to offer College of American Pathology (CAP)-standard companion diagnostic testing services in China for pharmaceutical and biotech companies conducting early phase clinical trials. This is great news for patients as China is one of the only countries in the world that requires all patient samples be tested in China,...

2014-08-05 08:33:41

Novel clinical trial matching protocol enables greater access to genomic profiling and targeted clinical studies for cancer patients nationwide. ANN ARBOR, Mich. and DENVER, Aug. 5, 2014 /PRNewswire-USNewswire/ -- Paradigm has announced today they have initiated genomic testing for Pharmatech's AccessPPM Cancer Registry. Pharmatech's AccessPPM is a cancer registry designed to collect EMR data and genomic information to help best match cancer patients with targeted clinical trials....

2014-08-05 08:33:24

QUÉBEC CITY, Aug. 5, 2014 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced a strategic co-promotion services agreement with ASCEND Therapeutics(®) US, LLC, ("ASCEND"). Under the terms of the agreement, expected to start in the fourth quarter of 2014, Aeterna Zentaris will use its newly established commercial structure to market, in specific U.S. territories, ASCEND's EstroGel(® )a non-patch transdermal U.S. Food & Drug...

2014-08-04 12:30:57

LONDON, Aug. 4, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Restless Legs Syndrome Global Clinical Trials Review, H1, 2014 http://www.reportbuyer.com/pharma_healthcare/research_r_d/clinical_trials/restless_legs_syndrome_global_clinical_trials_review.html Restless Legs Syndrome Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, "Restless Legs Syndrome Global Clinical Trials Review, H1, 2014" provides data on the...

2014-08-04 08:28:51

HAYWARD, Calif., Aug. 4, 2014 /PRNewswire/ -- Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the U.S. Food and Drug Administration (FDA) performed a re-inspection of the Company's Hayward, California manufacturing facility from June 16 to July 31, 2014. At the conclusion of the inspection, the FDA issued a Form 483 with seven inspectional observations, two of which are designated as repeat observations. The FDA did not provide any status or classification to these...


Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related